← Back to catalogue

Sirrus® Direct Gylcohemoglobin (HbA1c)

FDA UDI

Class II (US FDA UDI)

by Stanbio Laboratory, L.p.

Identity

Trade Name
Sirrus® Direct Gylcohemoglobin (HbA1c) FDA UDI
Generic Name
Glycated haemoglobin (HbA1c) IVD, kit, nephelometry/turbidimetry FDA UDI
Device Name
For the Quantitative Determination of Glycohemoglobin (HbA1c) in human blood. FDA UDI
Model / Reference
S0360-200 FDA UDI
Description
For the Quantitative Determination of Glycohemoglobin (HbA1c) in human blood. FDA UDI

Identifiers

Catalog Number
S0360-200 FDA UDI
Primary DI / UDI-DI
00657498001523 FDA UDI
FDA Product Code
LCP FDA UDI
GMDN Term
Glycated haemoglobin (HbA1c) IVD, kit, nephelometry/turbidimetry FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
864.7470 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Glycated haemoglobin (HbA1c) IVD, kit, nephelometry/turbidimetry

Sirrus® Direct Gylcohemoglobin (HbA1c) by Stanbio Laboratory, L.p. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Glycated haemoglobin (HbA1c) IVD, kit, nephelometry/turbidimetry.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI aca935fe-9314-48d9-86f0-28adb4d1b556 36 fields · synced May 30, 2026